Amundi Has $523,000 Holdings in Owens & Minor, Inc. (NYSE:OMI)

Amundi boosted its stake in shares of Owens & Minor, Inc. (NYSE:OMI) by 179.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,303 shares of the company’s stock after purchasing an additional 23,294 shares during the quarter. Amundi’s holdings in Owens & Minor were worth $523,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in OMI. Waldron Private Wealth LLC acquired a new stake in shares of Owens & Minor during the 4th quarter worth about $406,000. FMR LLC raised its holdings in Owens & Minor by 0.8% during the 3rd quarter. FMR LLC now owns 11,564,624 shares of the company’s stock worth $181,449,000 after buying an additional 90,862 shares during the period. JPMorgan Chase & Co. raised its holdings in Owens & Minor by 68.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after buying an additional 152,999 shares during the period. Foundry Partners LLC acquired a new stake in Owens & Minor during the 3rd quarter worth approximately $5,238,000. Finally, Algert Global LLC raised its holdings in shares of Owens & Minor by 189.4% in the third quarter. Algert Global LLC now owns 276,438 shares of the company’s stock valued at $4,337,000 after purchasing an additional 180,922 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Price Performance

Shares of NYSE:OMI opened at $9.53 on Friday. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The stock’s fifty day simple moving average is $10.52 and its two-hundred day simple moving average is $12.66. Owens & Minor, Inc. has a 1-year low of $6.07 and a 1-year high of $28.35. The stock has a market cap of $735.78 million, a PE ratio of -14.65, a price-to-earnings-growth ratio of 0.20 and a beta of 0.61.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.02. The company had revenue of $2.70 billion during the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.69 EPS. As a group, analysts forecast that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.

Owens & Minor announced that its Board of Directors has authorized a stock buyback plan on Friday, February 28th that authorizes the company to repurchase $100.00 million in shares. This repurchase authorization authorizes the company to reacquire up to 13.6% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

Insider Transactions at Owens & Minor

In other news, major shareholder Coliseum Capital Management, L bought 354,901 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average price of $9.19 per share, for a total transaction of $3,261,540.19. Following the transaction, the insider now directly owns 9,824,599 shares of the company’s stock, valued at $90,288,064.81. This represents a 3.75 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 3.59% of the stock is owned by insiders.

Analyst Ratings Changes

OMI has been the subject of several analyst reports. UBS Group decreased their target price on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Robert W. Baird boosted their target price on shares of Owens & Minor from $10.00 to $11.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. Finally, JPMorgan Chase & Co. dropped their price target on Owens & Minor from $14.00 to $10.00 and set an “underweight” rating for the company in a research note on Monday, March 10th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $13.75.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.